このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Health & Life マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

Does Health & Life (GTSM:1781) Have A Healthy Balance Sheet?

Feb 12

We're Not So Sure You Should Rely on Health & Life's (GTSM:1781) Statutory Earnings

Dec 22

CEO（最高経営責任者

Health & Life CEOがいない、あるいは彼らに関するデータがない。

Health & Life マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

Health & Life Co., Ltd., Annual General Meeting, Jun 21, 2024

Recent updates

Second quarter 2024 earnings released: NT$0.23 loss per share (vs NT$0.38 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: NT$0.30 (vs NT$0.25 loss in 1Q 2023)

Health & Life Co., Ltd., Annual General Meeting, Jun 21, 2024

Full year 2023 earnings released: NT$0.70 loss per share (vs NT$0.37 loss in FY 2022)

New major risk - Revenue and earnings growth

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$0.38 loss per share (vs NT$0.007 profit in 2Q 2022)

Full year 2022 earnings released: NT$0.37 loss per share (vs NT$1.32 loss in FY 2021)

First quarter 2022 earnings released: NT$0.24 loss per share (vs NT$0.46 profit in 1Q 2021)

Full year 2021 earnings released: NT$1.31 loss per share (vs NT$4.35 profit in FY 2020)

Third quarter 2021 earnings released: NT$0.47 loss per share (vs NT$4.53 profit in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: NT$0.61 loss per share (vs NT$0.36 profit in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.46 (vs NT$0.17 loss in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$4.34 (vs NT$1.61 loss in FY 2019)

New 90-day low: NT$21.50

Does Health & Life (GTSM:1781) Have A Healthy Balance Sheet?

New 90-day low: NT$23.80

We're Not So Sure You Should Rely on Health & Life's (GTSM:1781) Statutory Earnings

Third quarter 2020 earnings released: EPS NT$4.53

New 90-day low: NT$24.25

New 90-day low: NT$25.35

New 90-day low: NT$26.55

First half earnings released

CEO（最高経営責任者

Health & Life マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Health & Life Co., Ltd., Annual General Meeting, Jun 21, 2024

Recent updates

Second quarter 2024 earnings released: NT$0.23 loss per share (vs NT$0.38 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: NT$0.30 (vs NT$0.25 loss in 1Q 2023)

Health & Life Co., Ltd., Annual General Meeting, Jun 21, 2024

Full year 2023 earnings released: NT$0.70 loss per share (vs NT$0.37 loss in FY 2022)

New major risk - Revenue and earnings growth

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$0.38 loss per share (vs NT$0.007 profit in 2Q 2022)

Full year 2022 earnings released: NT$0.37 loss per share (vs NT$1.32 loss in FY 2021)

First quarter 2022 earnings released: NT$0.24 loss per share (vs NT$0.46 profit in 1Q 2021)

Full year 2021 earnings released: NT$1.31 loss per share (vs NT$4.35 profit in FY 2020)

Third quarter 2021 earnings released: NT$0.47 loss per share (vs NT$4.53 profit in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: NT$0.61 loss per share (vs NT$0.36 profit in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.46 (vs NT$0.17 loss in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$4.34 (vs NT$1.61 loss in FY 2019)

New 90-day low: NT$21.50

Does Health & Life (GTSM:1781) Have A Healthy Balance Sheet?

New 90-day low: NT$23.80

We're Not So Sure You Should Rely on Health & Life's (GTSM:1781) Statutory Earnings

Third quarter 2020 earnings released: EPS NT$4.53

New 90-day low: NT$24.25

New 90-day low: NT$25.35

New 90-day low: NT$26.55

First half earnings released

CEO（最高経営責任者

マネジメント基準チェック /04